Haymaker Acquisition Corp. III
HYACW
NASDAQ Capital Market0.68
USD
+0.05
- -
CIK
0001819253
Return %
Stock
S&P500
1Y
- -
18.44
3Y
18.66
63.65
5Y
-31.47
74.90
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Steven J. Heyer
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 501 Madison Avenue New York City NY United States of America
- IPO Date
- Apr 22, 2021
- CIK
- 0001819253
- Similar Companies
- Business
- Haymaker Acquisition Corp. III (NASDAQ:HYACW) is a special purpose acquisition company formed in 2020 and headquartered in New York, New York, with a focus on effecting mergers, capital stock exchanges, asset acquisitions, stock purchases, reorganizations, or similar business combinations with one or more businesses in the consumer and consumer-related products and services industries; it raised $317.5 million in its initial public offering in March 2021, offering units comprising Class A common stock and warrants exercisable at $11.50 per share, which began separate trading under HYAC and HYACW symbols in April 2021. The company, led by Chief Executive Officer and Executive Chairman Steven J. Heyer, President Andrew R. Heyer, and Chief Financial Officer Christopher Bradley, targeted growth-oriented entities and completed its initial business combination in May 2022 with biote LLC, a provider of customized hormone optimization therapies, forming biote Corp. (NASDAQ: BTMD) valued at approximately $737 million with $195 million in cash post-closing assuming no redemptions, enabling biote's expansion in clinical research, product development, and commercial operations across the United States. Post-merger, Haymaker Acquisition Corp. III's warrants continue trading as HYACW with an expiration in January 2026, while no significant developments such as new partnerships, funding rounds, or operational changes have been reported for the entity itself since the 2022 combination, which represented its primary strategic shift from a blank-check vehicle to a completed de-SPAC transaction.